Key result
PP2 completely blocks VEGF-induced endothelial G6PD translocation and cuts basal activity by ~25%.
Answers are grounded in this paper and cite their sources.
Demonstrates that c-Src mediates tyrosine phosphorylation of G6PD in endothelial cells, suggesting an essential mechanism driving VEGF-stimulated cell migration and angiogenesis.
OBJECTIVE: Glucose 6-phosphate dehydrogenase (G6PD) maintains cellular NADPH levels, which are essential for cellular functions, such as vascular endothelial growth factor (VEGF)-induced angiogenesis. The molecular mechanisms regulating G6PD in angiogenesis are not fully understood. Because tyrosine phosphorylation is a key regulatory pathway for VEGF-mediated endothelial cell (EC) responses, we investigated tyrosine phosphorylation of G6PD and the role of the nonreceptor tyrosine kinase Src. METHODS AND RESULTS: VEGF increased G6PD membrane translocation as measured by a plasma membrane sheet assay, whereas tyrosine kinase inhibitor PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo [3,4-d] pyramidine) decreased G6PD translocation by 100%. Furthermore, G6PD tyrosine phosphorylation and plasma membrane activity were increased by VEGF. In resting ECs, tyrosine kinase inhibitors PP2 and herbimycin A decreased basal G6PD activity by approximately 25%, whereas transfection with kinase inactive Src (KD-Src) decreased basal activity by approximately 30%. In mouse embryonic fibroblasts, Src-deficient (SYF) cells showed approximately 22% lower basal G6PD activity than Src-expressing S(+)YF cells. In addition, Src directly phosphorylated G6PD assayed by in vitro kinase assay. In ECs transfected with the G6PD mutants Y428F, Y507F (presumptive sites for Src-phosphorylation) or double mutant Y428F/Y507F, G6PD tyrosine phosphorylation was significantly decreased. Finally, G6PD tyrosine mutants (Y428F, Y507F, and Y428F/Y507F) decreased VEGF-mediated Akt phosphorylation and EC migration. CONCLUSIONS: G6PD activity and membrane association are regulated by Src-mediated tyrosine phosphorylation, which contributes to VEGF-mediated cellular responses in EC.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2009) studied VEGF-induced angiogenesis in endothelial cells. Tyrosine kinase inhibitors (PP2, herbimycin A), kinase-inactive Src (KD-Src), and G6PD tyrosine mutants vs. Resting or Src-expressing cells was evaluated on G6PD membrane translocation and basal activity. Tyrosine kinase inhibition with PP2 decreased VEGF-induced G6PD translocation by 100% and reduced basal G6PD activity in endothelial cells by ~25%.
Synapse has enriched 10 related papers. Consider them for comparative context: